← Back to Search

eAMS Smartphone App for Asthma (eAMS Trial)

N/A

Waitlist Available

Research Sponsored by Unity Health Toronto

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients with asthma, as determined by a validated electronic chart record search algorithm for asthma; patients >/= 16 years of age.

Must not have

Patients who received an AAP within the last 6 months (from their primary care physician, a respirologist, or any other source).

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will test a smartphone app to help manage asthma and will include an electronic asthma self-management app.

Who is the study for?

This trial is for asthma patients aged 16 or older, identified by a validated electronic record search. It's open to those who haven't received an Asthma Action Plan (AAP) in the last six months. Pregnant individuals are excluded as AAP recommendations may differ for them.

What is being tested?

The study tests an Electronic Asthma Management System (eAMS). Patients use a smartphone app to complete questionnaires that help doctors assess asthma control and advise on medication changes, generating an electronic AAP based on responses.

What are the potential side effects?

Since this trial involves using an electronic management system rather than medication, traditional side effects aren't expected. However, there might be indirect consequences like anxiety or stress from technology use or data misinterpretation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 16 or older with asthma confirmed by medical records.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have been prescribed an AAP in the last 6 months.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Proportion of Received AAP

Secondary study objectives

Any Medication Change

Appropriate Medication Change

Documented Asthma Control

+6 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Electronic Asthma Management System: eAMS Intervention eAMS consists of simple questionnaire completed either through an app on a patient's smartphone or tablet computer, a computerized clinical decision support system which then processes these data to produce a set of asthma care recommendations for the clinician, and a printable asthma action plan that is given to patients. eAMS will also provide access to a patient-oriented asthma management tool called Breathe.

Group II: ControlActive Control1 Intervention

Electronic Asthma Management System: eAMS - Control At control sites, eligible clinicians will be offered access to the web-based clinician-oriented asthma action plan (AAP) educational module produced by the Lung Association, copies of the Canadian Asthma Guidelines, and standard fillable paper-based AAPs (the eAMS will be offered after study end).

0 / 2Eligibility criteria met